source
- Scribe aims for $96M IPO to fund clinical push for lipid-lowering genetic medsScribe Therapeutics has put its IPO plans down on paper, showing the genetic medicine company hopes to raise $96 million through its public listing.Fierce Biotech · 12d ago↗ source
- BMS expands AI footprint with Nvidia, aiming for ‘most powerful AI factory in life sciences’Bristol Myers Squibb has entered into an expanded collaboration with Nvidia to create the biggest supercomputer for drug R&D, according to the announcement.Fierce Biotech · 12d ago↗ source
- Early Alert: Intravascular Administration Set Issue from BaxterBaxter administration sets may have air bubbles in the drip chamber and tubing, which may result in air being delivered through the IV line to the patient.